The Future of Aseptic Pharmacy Services in England: Report on Phase 1 of the NHSI Review (Feb 2019)

Specialist Pharmacy Services | February 2019 | The Future of Aseptic Pharmacy Services in England: Report on Phase 1 of the NHSI Review (Feb 2019)

NHS Improvement undertook a review of the provision pharmacy aseptic services including MHRA licensed, unlicensed an outsourced (both from NHS Providers and non-NHS commercial suppliers) activity. Product categories included in the review are chemotherapy, parenteral nutrition, clinical trials / investigational medicinal products, and pharmacy-led radiopharmacy.

Specific aspects of these services on which information was sought included: geographical location, capacity (staff and facilities), estate & equipment, management structure, staffing establishment, operational costs, service hours, range of products & services provided, and customer base.

This report summarises findings from the first phase of the Review and recommended next steps to be taken in Phase 2, which started in February 2019 (Source: Specialist Pharmacy Services 

PowerPoint The Future of Pharmacy Aseptic Services in England Feb 19

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s